1. The EP1/EP3 receptor agonist 17-pt-PGE2 acts as an EP4 receptor agonist on endothelial barrier function and in a model of LPS-induced pulmonary inflammation
   Anna Theiler et al, 2016, Vascular Pharmacology CrossRef
2. EP1 receptor antagonism mitigates early and late stage renal fibrosis
   Jean‐Claude Kresse et al, 2022, Acta Physiologica CrossRef
3. Prostaglandin E2 receptors as therapeutic targets in renal fibrosis
   Henricus A.M. Mutsaers et al, 2022, Kidney Research and Clinical Practice CrossRef
4. PP2 Ameliorates Renal Fibrosis by Regulating the NF-κB/COX-2 and PPARγ/UCP2 Pathway in Diabetic Mice
   Jinying Wei et al, 2021, Oxidative Medicine and Cellular Longevity CrossRef
5. The Roles of Various Prostaglandins in Fibrosis: A Review
   Ke Li et al, 2021, Biomolecules CrossRef
6. EP4 knockdown alleviates glomerulosclerosis through Smad and MAPK pathways in mesangial cells
   Yingjie Cao et al, 2018, Molecular Medicine Reports CrossRef